PAF1-mediated transcriptional reprogramming confers docetaxel resistance in advanced prostate cancer.
Muniyan S, Vengoji R, Nimmakayala RK, Seshacharyulu P, Perumalsamy B, Alsafwani ZW, Kakar SS, Smith LM, Shonka N, Teply BA, Lele SM, Ponnusamy MP, Batra SK.
Muniyan S, et al. Among authors: perumalsamy b.
Cancer Lett. 2025 Jan 28;609:217355. doi: 10.1016/j.canlet.2024.217355. Epub 2024 Nov 26.
Cancer Lett. 2025.
PMID: 39603380